About the Company
CM Life Sciences was founded to take advantage of a dynamic life science sector buoyed by innovation yet fragmented, where many companies are under-resourced and under-scaled. Significant and under-appreciated opportunities for consolidation are ready for engagement by a team versed in the trends and themes, and who can bring together the strongest of the new companies and management teams to capitalize on near- and far-term opportunities.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CMLF News
CM Life Sciences III
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
SPAC Wrap: Is it time to Buy IPOs again? CMLT Rises Big. 2 new M&A Deals (CAHC, MCAD)
New issue CM Life Sciences 3 (CMLT) surged on its first day of trading, potentially kicking off another wave of SPAC IPO pricings. Two new M&A deals both rose on deal announcement. The day started ...
CBD Life Sciences Inc CBDL
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
EQRx (EQRX) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Health/Life Sciences
2024 at 6:05 pm Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 billion in cash, a 38% premium ...
TLSI TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic ...
ENDRA Life Sciences Inc Registered Shs NDRA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
VGLS VG Life Sciences Inc.
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic ...
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call ... is that the World Health Organization has issued a new ICD-10-CM code specifically for fatty liver disease. The ICD-10-CM is ...
Phoenix Healthcare and Life Sciences Summit
Previously, Allie was a Senior Consultant at Deloitte where she worked at the intersections of Biodefense, Life Sciences ... design-build, CM@R and IPD or “Big Room” experience.
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 28, 2024--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of ... intellectual property portfolio. New ICD-10-CM code issued, which paves the way for improved NAFLD ...
Loading the latest forecasts...